LEAGUE TABLES - Biotech firms aim to branch out
Australasian biotech companies have been overlooked and undervalued, down to a combination of investor disappointment and a lack of understanding. It has led the firms to seek out merger opportunities internationally, reports mergermarket.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: